Pharma Marketing Network

In this 3-minute audio snippet, Rob Halkes, , MHA, Managing Consultant/Owner, Health Business Consult, talks about the structural changes needed to implement a new commercial model for a pharmaceutical marketing approach, which provides added value to medicines, helps physicians provide better care for their patients, and builds a sustainable relationship with customers.

Do you hate your job in pharma? Perhaps, like a friend of mine, your position got eliminated after many years of loyal service. But it may be a blessing in disguise if the behavior of Big Pharma is more and more at odds with your personal values. If so, you have options for cleansing your soul.

In this 4.5-minute audio snippet, R.J., President and CEO of eHealthcare Solutions, talks about programmatic ad buying or the 'Auction-based' model.

In this 3-minute audio snippet, Preeti Pinto, a regulatory consultant and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca, talks about how regulatory-savvy pharma marketers are in a better position to challenge their regulatory colleagues when they say 'No.'

Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.

In this 2-minute audio snippet, Pharmaguy talks about his decision to 'break away' from John Mack in order to focus his efforts on speaking at live events and webinars and to more fully engage with his many followers via social networks such as Twitter, Pharma Marketing Blog, Tumblr, Facebook, and Google+.

In this 3-minute audio snippet, Peter Kirk, CEO, Sermo, talks about the differences between Doximity and Sermo with regard to online physician discussions and the benefits of anonymity.

In this 3-minute audio snippet, Peter Houston, founder of Flipping Pages Media Ltd, discusses the pros and cons of Tumblr and whether it is possible for pharma marketers to get involved with Tumblr. Is it too Early?

In this 3-minute audio snippet, Paul Ivans, President and CEO, Evolution Road, LLC, reviews comments he submitted to the FDA regarding clarification of FDA's intent on how it will regulate the placement of pharma promotional messages on independent 3rd-party Web sites.

In these audio snippets, several anonymous patients and patient advocates tell why they are in favor of or against allowing pharmaceutical companies to promote/advertise off-label uses of drugs directly to patients.